2 recruiting, 1 active not recruiting, 1 terminated. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Vasovagal Syncope (VVS): new trials by email Literature Review of Vasovagal Syncope (VVS) trials Research Report on Vasovagal Syncope (VVS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assesment of the Clinical Benefit of Provocation on Tilt-table in SYNCope Patients, TiltSYNC-trial biofeedback and standard of care with tilt table testing, no tilt table testing - Vasovagal Syncope (VVS) | Not applicable | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 238 | 2025-10-30 | 2026-03-11 |
| A Warning Red Flag Classification System to Predict Risk of Vasovagal Event During Office Hysteroscopy Office hysteroscopy - Vasovagal Syncope (VVS), Presyncope | Active not recruiting | Tanvir Hospital | 100 | 2025-06-20 | 2026-06-30 | |
| A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11) Ondansetron, Placebo - Vasovagal Syncope (VVS), Syncope | Phase 2 | Recruiting | University of Calgary | 70 | 2023-06-01 | 2024-05-10 |
| Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS) Northera (Droxidopa), Placebo - Postural Tachycardia Syndrome (POTS), Vasovagal Syncope (VVS) | Phase 2 | Terminated | New York Medical College | 30 | 2015-09-01 | 2025-05-23 |
Syncope (4) · Syncope, Vasovagal (4) · Orthostatic Intolerance (1) · Postural Orthostatic Tachycardia Syndrome (1)
Autonomic Nervous System Diseases (4) · Consciousness Disorders (4) · Nervous System Diseases (4) · Neurobehavioral Manifestations (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Primary Dysautonomias (4) · Signs and Symptoms (4) · Unconsciousness (4) · Orthostatic Intolerance (3)
Droxidopa (1) · Ondansetron (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · New York Medical College (1) · Tanvir Hospital (1) · University of Calgary (1)
Canada (1) · India (1) · Netherlands (1) · United States (1)
Frederik J de Lange, MD, PhD (1) · Julian M Stewart, M.D., Ph.D. (1) · Tanvir Dr. (1)